Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study on Liver Fibrosis Assessment Using 68Ga-FAPI-46 Imaging in Patients with Suspected or Confirmed Nonalcoholic Steatohepatitis

Recruiting

2 1 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on Efruxifermin for Patients with Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Recruiting

3 1
Investigated Diseases:
- Hepatic fibrosis
Investigated Drugs:
- Efruxifermin
Study on Efruxifermin for Patients with Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) or Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Recruiting

3 1
Investigated Diseases:
- Hepatic cirrhosis
Investigated Drugs:
- Efruxifermin
+2
Study of Namodenoson Treatment in Patients with Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Recruiting

2 1
Investigated Drugs:
- Namodenoson
A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Recruiting

3 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
+4
Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Recruiting

3 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
+4
Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

Not yet recruiting

2 1
Investigated Drugs:
- Allogeneic Faecal Microbiota, Pooled
Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

Not yet recruiting

3 1 1 1
Investigated Diseases:
- Metabolic dysfunction-associated steatohepatitis
Investigated Drugs:
- Empagliflozin
Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

Not recruiting

2 1
Investigated Drugs:
- Efinopegdutide
Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

Not recruiting

3 1
Investigated Drugs:
- Lanifibranor
+5

Opportunities for Healthy Volunteers

Matched clinical trials

We use cookies